EP1325084A2 - Colorants du type pyridine et quinoleine utilises comme marqueurs pour des biomolecules, des polymeres, des medicaments et des particules - Google Patents

Colorants du type pyridine et quinoleine utilises comme marqueurs pour des biomolecules, des polymeres, des medicaments et des particules

Info

Publication number
EP1325084A2
EP1325084A2 EP99963383A EP99963383A EP1325084A2 EP 1325084 A2 EP1325084 A2 EP 1325084A2 EP 99963383 A EP99963383 A EP 99963383A EP 99963383 A EP99963383 A EP 99963383A EP 1325084 A2 EP1325084 A2 EP 1325084A2
Authority
EP
European Patent Office
Prior art keywords
radicals
quinoline
group
optionally
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99963383A
Other languages
German (de)
English (en)
Inventor
Otto Samuel Wolfbeis
Mario Probst
Frank Lehmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19856152A external-priority patent/DE19856152A1/de
Priority claimed from DE19954934A external-priority patent/DE19954934A1/de
Application filed by Individual filed Critical Individual
Publication of EP1325084A2 publication Critical patent/EP1325084A2/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
    • C09B23/06—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups three >CH- groups, e.g. carbocyanines
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/0066—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain being part of a carbocyclic ring,(e.g. benzene, naphtalene, cyclohexene, cyclobutenene-quadratic acid)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Definitions

  • the invention relates to quinolinium or pyridinium derivatives, which are particularly suitable as markers for biomolecules, polymers, drugs and particles.
  • this object is achieved by a quinolinium or pyridinium derivative of the general formula (Ia), (Ib), (Ha) or (IIb):
  • the compounds according to the invention are - to varying degrees - free from the disadvantages of the markers of the prior art.
  • the compounds according to the invention thus have excellent photo and storage stability.
  • the compounds according to the invention, as described below, can be obtained in high yields using simple synthesis steps, starting from commercially available starting products.
  • the compounds also have high extinction coefficients or fluorescence quantum yields.
  • Another advantage of the quinoline or pyridine derivatives according to the invention is that the optical properties, such as the absorption behavior, are generally not deteriorated in the presence of and in particular after binding to carrier molecules, such as proteins or nucleic acids. As can be seen, for example, from FIG.
  • All compounds according to the invention have a nitrogen-containing 6-ring heterocycle as one of the substituents on the polymer grouping.
  • the rest Z comprises the polymer grouping and the second auxochrome group.
  • the compounds according to the invention are reactive dyes, ie dyes which, in addition to the color-giving chromophoric component, comprise at least one reactive component, via which they can be covalently bound to carrier substances by reaction with functional groups.
  • at least one of the radicals R to R 15 comprises a reactive group which enables covalent linkage to a carrier molecule.
  • the radicals R to R 15 can themselves represent the reactive group.
  • the at least one preferably has
  • Radical R- to R 15 which comprises a reactive group, but the
  • W represents a spacer group via which the reactive group is bonded to the actual chromophore.
  • the spacer group preferably has the general one
  • the spacer group can be straight-chain or branched. However, the reactive group can also be bound to the chromophore via other spacer groups.
  • the reactive group can enable a covalent bond to the amine and / or hydroxyl functions of the carrier substance, for which the functional groups isothiocyanate, isocyanate, monochlorotriazine, dichlorotriazine, aziridine, sulfonyl halide, N-hydroxysuccinimide ester, imido ester, glyoxal or aldehyde are particularly suitable.
  • the reactive group is preferably selected from Maleiimide or iodoacetamide selected.
  • the reactive group phosphoramidite is particularly suitable for labeling nucleic acids, such as DNA or RNA, or their fragments.
  • the compounds according to the invention comprise at least one reactive group. While theoretically each of the radicals R to R may include 15 a reactive group dyes are a maximum of three, more preferably at most two reactive groups are preferred. Most preferred are compounds in which exactly one radical R to R 15 contains a reactive group.
  • At least one of the radicals R. to R 15 of the compounds comprises an ionizable or ionized group.
  • This ionizable or ionized group determines the hydrophilic properties of the dye.
  • This at least one residue is preferably selected so that a water-soluble dye is obtained, a low water solubility being sufficient, in which the dye does not precipitate out of an aqueous solution
  • ionizable groups are in particular groups which form ions in aqueous environments, for example by cleavage or recording a proton.
  • the ionizable or ionized group is preferably selected from S0 3 " , PO 3 2 ' , COO " and N (R 16 ) 3 + , with groups belonging to
  • R 16 means C 1 -C 4 alkyl. It is possible that the at least one residue R-,
  • R 15 itself represents the ionizable or ionized group. It is also possible for a radical R which contains an ionizable or ionized group to R 15 to have the general formula W1, in which I represents the ionizable or ionized group and W represents a spacer group, as defined above.
  • the remaining radicals R 1 to R 15 which do not comprise any reactive group or ionizable or ionized group, are selected independently from the following groups on each occurrence: hydrogen, Halogen, in particular fluorine, chlorine, bromine or iodine,
  • Hydrocarbon chains can be unbranched or branched chains which optionally contain one or more olefinically unsaturated units, the hydrocarbon chains preferably having 1 to 6 and most preferably 1 to 4 carbon atoms,
  • C 4 -C 14 aryl which may optionally contain heteroatoms, in particular selected from N, 0 and / or S, phenyl and naphthyl radicals being particularly preferred, nitro,
  • (Dialkyl) amino where it is preferably primary or secondary amino groups and the alkyl radicals are each independently one in particular a C 1 -C 6 -alkyl and particularly preferably a C 1 -C 4 -alkyl radical which can be straight-chain or branched and can optionally contain one or more olefinically unsaturated units.
  • radicals R and R 12 together with the polymethine carbons to which they are attached, can also form 4-, 5- or 6-membered ring systems which form a bridge between the polymethine system.
  • the at least one reactive group present on the radicals R ⁇ - to R 15 can then also on this
  • Ring systems are bound. It is also possible for one or more of the radicals R to R 10 , which are bonded to the auxochromic ring systems of the compounds according to the invention, to form more condensed aromatic and / or heterocyclic rings with them.
  • m can finally stand for the numerical values 1, 2 or 3, which then results in three, five or seven carbon-atomic polymethine chains.
  • the structural unit is in the event that the radicals R and R 12 form a ring bridge
  • radicals A, B, C, D, E, F and G are independently selected from
  • Halogen in particular fluorine, chlorine, bromine or iodine, C.-Cg-alkoxy, CC 18 -alkyl, C r C 18 -acyl, where the alkyl chains can be straight-chain or branched and can optionally contain one or more olefinically unsaturated units, where the hydrocarbon radicals preferably have 1 to 6 and particularly preferably 1 to 4 carbon atoms, C 4 -C 14 aryl, which optionally contains heteroatoms, in particular N,
  • Dialkyl amino the (dialkyl) amino radical preferably comprising primary or secondary amino groups and the alkyl radicals each preferably 1 to
  • 1 8 more preferably 1 to 6 and particularly preferably 1 to 4 carbon atoms, may be straight-chain or branched and may optionally have one or more olefinically unsaturated units.
  • At least one of the radicals A, B, C, D, E, F and G can be a reactive group which forms a covalent bond with a carrier substance
  • A, B and C can also represent a residue selected from O, S,
  • R 18 is a Ci-Cg-aliphatic or C 4 -C 14 - aromatic radical, which may optionally be substituted.
  • Suitable substituents are, for example, the reactive or ionizable ⁇ or ionized groups.
  • R is preferably the radical (CH 2 ) n COOH or (CH 2 ) n NH 2 .
  • D can furthermore represent Cl or a C 4 -C 14 aromatic or a CC 18 aliphatic ring system, which may optionally have a reactive group selected from isothiocyanates, isocyanates, monochlorotriazines, dichlorotriazines, azeridines, sulfonyl halides, N-hydroxysuccinimide esters, imidoesters, glyoxals , Aldehydes, maleiimides, iodoacetamides and phosphoramidites can be substituted.
  • a reactive group selected from isothiocyanates, isocyanates, monochlorotriazines, dichlorotriazines, azeridines, sulfonyl halides, N-hydroxysuccinimide esters, imidoesters, glyoxals , Aldehydes, maleiimides, iodoacetamides and phosphoramidites can be substituted
  • the invention relates to substituted quinoline and pyridine derivatives of the general formula (la) or (Ib) or (lla) or (Mb)
  • the reactive group can be selected from the following functionalities: isothiocyanates, isocyanates, monochlorotriazines, dichlorotriazines, aziridines, sulfonyl halides, N-hydroxysuccinimide esters, imido esters, glyoxal or aldehydes for amine and hydroxyl functions or maleimides or iodoacetamides for thiol functions and Phosphoramidites for labeling DNA or RNA or their fragments.
  • These reactive groups can also be bonded to the actual chromophore via spacer groups of the general empirical formula - (CH 2 ) n -, where n can assume values from 1 to 1 8;
  • the substituents R and R 12 also include bridging via four-, five- and six-membered ring systems, where one or more of the above-mentioned reactive groups can also be located on this.
  • Such ring bridges of the polymethine chain are shown below. So it can Structure stand for or
  • the structural unit can stand for
  • substituents A, B, C, D, E, F and G can have the same functionalities as R T to R 15 .
  • A, B and C can be O, S, C (CN) 2 or NRg, where R 18 in NR 18 is an aliphatic or aromatic or a reactive aliphatic or aromatic radical such as (CH 2 ) ⁇ COOH or (CH 2 ) n NH 2 can stand.
  • D can furthermore stand for Cl or an aromatic or aliphatic ring system, to which reactive substituents are optionally attached analogously to R to R 15 ;
  • At least one of the substituents R to R 15 is an ionizable or ionized substituent such as S0 3 ' , PO 3 2 " , COO " or N (R 16 ) 3 + , which determines the hydrophilic properties of this dye;
  • the definitions for the radicals are in each case as described hereinbefore.
  • the compounds according to the invention in particular have an absorption or fluorescence in a range> 400 nm, preferably> 450 nm, particularly preferably> 600 nm and most preferably> 630 nm and up to preferably 900 nm.
  • the use of marker substances with an absorption in the range> 600 nm enables high penetration depths in the tissue, since there is no disturbing absorption by the tissue in this wavelength range. It is furthermore possible, by suitable selection of the ring systems or the substituents, to adjust the dyes according to the invention to suit all diode light sources.
  • the dyes according to the invention Due to the choice of the substituents according to the invention, in particular the choice of the quinolinium or pyridinium residues, which are six-ring heterocycles, the dyes according to the invention have an absorption maximum which is in the long-wave range in comparison to conventionally substituted polymethine dyes with the same polymethine chain length. In this way it is possible to produce absorbent dyes with relatively short polymethine chain lengths in the long-wave range. Since longer polymethine chains in particular are susceptible to degradation, a higher stability of the dyes according to the invention can be obtained.
  • the invention further comprises a process for the preparation of a reactive substituted quinoline or pyridinium derivative according to one of the preceding claims, comprising the steps of: a) providing a pyridine or quinoline heterocycle which has a methyl substituent in the ortho-para position, b) alkylating the ortho - or para-methyl-substituted pyridine or quinoline heterocycle on the nitrogen atom, a salt or an inner salt being formed, c) adding a C, C 3 or C 5 building block to the ortho or para methyl group, d) forming a reactive polymethine dye by reacting with another heterocyclic salt or inner salt.
  • the alkylation of the ortho- or para-methyl-substituted pyridine or quinoline heterocycle on the nitrogen atom is preferably carried out at a temperature of 110 to 150 ° C., it being possible to use all conventional alkylating reagents.
  • the alkylation can be carried out either without solvents or with customary solvents used for the alkylation.
  • a C, C 3 or C 5 building block is preferably added to the ortho or para methyl group at the boiling point (under reflux) using a solvent.
  • Preferred solvents are alcohols, such as ethanol or methanol, and a mixture of butanol and toluene.
  • a polymethine dye by reaction with a further heterocyclic salt or inner salt also preferably takes place in a solvent, in particular an alcohol, such as ethanol or methanol or a butanol / toluene mixture.
  • a solvent in particular an alcohol, such as ethanol or methanol or a butanol / toluene mixture.
  • the reactive group is activated by one or more of the substituents R 1 to R 15 after the preparation of the polymethine dye.
  • the activation is preferably carried out in a solvent such as DMF, DMSO, a slightly alkaline buffer such as PBS or a bicarbonate buffer at room temperature, preferably at 10 ° C. to 50 ° C.
  • the salt or inner salt used in step d) is preferably a nitrogen-containing heterocycle, the nitrogen carrying a positive charge.
  • Synthesis building blocks which are required for the preparation of the dyes according to the invention are commercially available. These include, for example, lepidine, quinaldine, 2-picoline, 4-picoline, 9-methylacridine, benzothiazole, 2,3,3-trimethylindolenine and 2,3,3-trimethyl-4,5-benzo-3H-indole.
  • hydrophilic and reactive groups can also easily be carried out by alkylating the heterocyclic nitrogen (R 14 , R 15 ) with suitable reagents, for example ⁇ -haloalkanoic acids, ⁇ -haloalkyiacetates, sultones, ⁇ -haloalkylphosphonic acids or their esters.
  • suitable reagents for example ⁇ -haloalkanoic acids, ⁇ -haloalkyiacetates, sultones, ⁇ -haloalkylphosphonic acids or their esters.
  • a C ,, C 3 or C 5 building block is then added to the reactive methyl group of the heterocycle. This is done, for example, by reaction with N, N'-diphenylformamidine, orthocarboxylic acid esters, malondialdehyde dianil or its hydrochloride, malondialdehyde tetraacetal, squaric acid (or its derivatives), glutacondialdehyde dianil or its hydrochloride or using the
  • a symmetrical or asymmetrical polymethine dye is obtained, which usually carries a reactive group (R ⁇ ... R 15 ).
  • a compound (1) which is a salt, obtained by alkylation of a paramethylquinoline at 110 ° C. to 150 ° C. is first reacted with a C building block under reflux in ethanol / methanol or butanol / toluene.
  • the C building block is attached to the methyl group, so that compound (3) has two (from the final three) C atoms of the polymethine chain.
  • the compound (3) is then reacted in an alcohol with a heterocyclic inner salt (compound 2) which also contains an ionized group (S0 3 ).
  • connection PB-630 is formed.
  • PB-630 is then activated at room temperature in a solvent such as DMF to form the PB-630-NHS ester.
  • the resulting product absorbs and fluoresces in the spectral range above 400 nm, in particular above 450 nm. This means that its fluorescence can be excited with - diode light sources and the fluorescence signal can be excited using a suitable optical device detectable.
  • substituted quinoline or pyridine derivatives of the general formula (la) or (Ib) or (lla) or (Mb) can be used as dyes for the optical labeling of carrier substances, in particular proteins, nucleic acids such as DNA or RNA, biological cells, lipids, polymers or pharmaceuticals can be used.
  • the functional groups of the compounds of the general formula (Ia) or (Ib) or (Ila) or (Mb) are the reactive ones with appropriate selection Group is able to covalently couple to an OH-NH 2 or SH function. This creates a system for the qualitative or quantitative determination of proteins, nucleic acids such as DNA or RNA, biological cells, lipids, organic or inorganic polymers or pharmaceuticals.
  • This coupling reaction can be aqueous, preferably predominantly aqueous. Solution and preferably at room temperature, in particular between 1 0 ° C and 50 ° C. This creates a conjugate, which preferably has fluorescent properties.
  • Both the compounds of the general formula (la) or (Ib) or (lla) or (Mb) and systems produced therefrom can be determined in optical, in particular fluorescence-optical qualitative and quantitative determination methods, including immunoassays, hybridization methods, chromatographic or electrophoretic methods and the high-throughput method. Screenings are used.
  • Table 1 shows the width of the through
  • the compounds according to the invention are particularly suitable for use as a dye for optically marking a carrier substance.
  • the marking is preferably carried out by covalent coupling of the compound to a suitable functional group of the carrier substance, for example an OH, NH 2 or SH group.
  • the carrier substance is preferably selected from biomolecules, such as proteins, peptides, nucleic acids, such as DNA or RNA and lipids, and from organic, biological and / or inorganic oligomers or polymers as well as from drugs, biological cells and also from polymer particles.
  • the compounds according to the invention can also be used for coloring inorganic or organic polymer particles, the coloring being possible both covalently and non-covalently, for example by incorporation.
  • the coloring compound can be introduced into the polymer particles or arranged on the surface of the polymer particles.
  • polymer particles with a diameter of 10 nm to 5 ⁇ m are colored.
  • Magnetic particles, in particular polymer particles with a magnetic core, are particularly preferably colored or marked, since numerous detection or separation methods can be carried out in a simple manner with such particles.
  • the invention further comprises a method for the qualitative and / or quantitative detection of an analyte, which is characterized in that a sample containing the analyte is reacted with a quinoline or pyridine derivative according to the invention and the quinoline or pyridine derivative via the reactive group covalently couples to the analyte and the conjugate of quinoline or pyridine derivative and analyte is determined.
  • the analyte is preferably selected from biological molecules, such as proteins, Nucleic acids, e.g. B. DNA or RNA, lipids, drugs, inorganic or organic oligomers and / or polymers, biological cells and polymer particles.
  • the analyte preferably has an OH, NH 2 or SH function to which the quinoline or pyridine derivative is covalently coupled.
  • a specific binding reagent for example a nucleic acid hybridization probe, an antibody or an antigen or a partner of a specific binding pair, for example biotin or avidin, is coupled with the dye according to the invention and then the conjugate of the coupled binding partner and analyte is detected.
  • the compounds according to the invention can be used in aqueous solution, so that the coupling reaction is preferably carried out in aqueous solution.
  • optical properties in particular the absorption and fluorescence properties of the dyes according to the invention can be adjusted by a suitable choice of the auxochrome groups (cf. e.g. Table 1 in FIG. 2).
  • the optical properties are preferably set such that the conjugate of dye and analyte has fluorescent properties.
  • Optical, in particular fluorescence-optical determination methods can be used to determine the labeled conjugates, for example immunoassays, hybridization methods, chromatographic or electrical methods and high-throughput screening.
  • the present invention relates to water-soluble marker dyes which are derived from the pyridine heterocycle. You are able to bind with biomolecules such as. B. proteins, lipids, polynucleotides, DNA, drugs or pharmaceuticals as well as with polymer particles. They are used for staining, especially fluorescent labeling of these materials.
  • the labeled molecules or particles can then in optical, in particular fluorescence-optical determination methods are used. Typical methods are based on the reaction of dye-labeled antigens, antibodies or DNA segments with the respective complementary species.
  • the reagents required to carry out the methods according to the invention can be provided in the form of a reagent kit.
  • Such a reagent kit contains, for example, a reactive dye for coupling to an analyte as well as suitable buffers or a binding partner coupled with a reactive dye for the analyte sought and suitable buffers and optionally further auxiliary reagents.
  • Figure 1 shows the absorption (left side) or fluorescence spectra
  • FIG. 2 shows Table 1, in which the absorption maxima of various trimethine compounds according to the invention are shown for different end groups.
  • the trimethine compounds in Table 1, in which both end groups are bonded to the methine unit via a hetero five-membered ring, are given as comparative examples.
  • PB-630 35 mg was dissolved in a mixture of 1 ml of DMF, 1 ml of 1,4-dioxane and 0.5 ml of water. 25 mg of TSTU and 1 l of p ⁇ diisopropylethylamine were added. The reaction mixture was then stirred for 50 minutes at room temperature and then filtered. The solvent was then stripped off and the product was dried in a desiccator over P 2 O 5 . 6.
  • PB-630 NHS esters (approx. 0.5 mg) were dissolved in 50 ⁇ l DMF. 5 mg HSA were dissolved in 750 ⁇ l bicarbonate buffer (0.1 mol / l, pH 9.0). The dye solution was slowly added to the protein solution and stirred for 20 hours at room temperature. The reaction mixture was dialyzed against a phosphate buffer (22 mmol / l, pH 7.2) using a dialysis membrane (1 500 FT, Union Carbide) with a cut-off of 1 0.000.
  • FIG. 1 shows the fluorescence spectra of dissolved PB-630 and of PB-630 covalently bound to HSA (conjugate prepared according to
  • Example 7 The integral fluorescence intensity increased six-fold when bound to the protein.
  • the particle suspension was a solution of the desired dye, eg. B. 1 - (3-Methyl-benzothiazol-2-yl) -3- (1 -octadecyl- ⁇ 4> Quinolyl) trimethinium perchlorate, (10 mg in 1 ml toluene) added in 20 ⁇ l portions. Care was taken to ensure that a further portion was only added when the previous portion had completely dissolved and was no longer on the surface of the stirred suspension.
  • the desired dye eg. B. 1 - (3-Methyl-benzothiazol-2-yl) -3- (1 -octadecyl- ⁇ 4> Quinolyl) trimethinium perchlorate, (10 mg in 1 ml toluene) added in 20 ⁇ l portions. Care was taken to ensure that a further portion was only added when the previous portion had completely dissolved and was no longer on the surface of the stirred suspension.
  • the particles obtained in this way have a fluorescence with a maximum at 652 nm.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des colorants marqueurs miscibles avec l'eau, qui dérivent de l'hétérocycle pyridine. Ils peuvent se lier avec des biomolécules telles que des protéines, des lipides, des polynucléotides, de l'ADN, des médicaments ou des produits pharmaceutiques, et également avec des particules polymères. Ils servent à la coloration, en particulier au marquage fluorescent de ces matériaux. Les molécules ou particules ainsi marquées peuvent ensuite être utilisées pour la mise en oeuvre de procédés de détermination optique en particulier de détermination optique par fluorescence. De tels procédés typiques reposent sur la réaction d'antigènes, d'anticorps ou de segments d'ADN marqués par colorant avec l'espèce complémentaire.
EP99963383A 1998-12-05 1999-12-03 Colorants du type pyridine et quinoleine utilises comme marqueurs pour des biomolecules, des polymeres, des medicaments et des particules Withdrawn EP1325084A2 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19856152 1998-12-05
DE19856152A DE19856152A1 (de) 1998-12-05 1998-12-05 Pyridin- und Chinolinfarbstoffe als Marker für Biomoleküle, Polymere und Arzneistoffe
DE19954934 1999-11-16
DE19954934A DE19954934A1 (de) 1999-11-16 1999-11-16 Verfahren zur Solubilisierung von optischen Markern
PCT/EP1999/009471 WO2000034394A2 (fr) 1998-12-05 1999-12-03 Colorants du type pyridine et quinoleine utilises comme marqueurs pour des biomolecules, des polymeres, des medicaments et des particules

Publications (1)

Publication Number Publication Date
EP1325084A2 true EP1325084A2 (fr) 2003-07-09

Family

ID=26050584

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99963383A Withdrawn EP1325084A2 (fr) 1998-12-05 1999-12-03 Colorants du type pyridine et quinoleine utilises comme marqueurs pour des biomolecules, des polymeres, des medicaments et des particules

Country Status (2)

Country Link
EP (1) EP1325084A2 (fr)
WO (1) WO2000034394A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1312479C (zh) * 2003-08-08 2007-04-25 清华大学 一种纳米荧光磁粒及其制备方法
GB0615211D0 (en) * 2006-07-31 2006-09-06 Ge Healthcare Uk Ltd Asymmetric flouro-substituted polymethine dyes
CN103804370A (zh) * 2014-02-08 2014-05-21 南京博炫生物科技有限公司 一种荧光染料化合物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138551A (en) * 1975-03-18 1979-02-06 Ciba-Geigy Ag Spectral sensitization of photographic material and new spectral sensitizers
US5571388A (en) * 1984-03-29 1996-11-05 Li-Cor, Inc. Sequencing near infrared and infrared fluorescense labeled DNA for detecting using laser diodes and suitable labels thereof
US5268486A (en) * 1986-04-18 1993-12-07 Carnegie-Mellon Unversity Method for labeling and detecting materials employing arylsulfonate cyanine dyes
DE3912046B4 (de) * 1988-09-02 2004-03-25 Carnegie Mellon University Verfahren zum Markieren einer Komponente einer wäßrigen Flüssigkeit und lumineszenzphotostabiles Reaktionsprodukt
US5658751A (en) * 1993-04-13 1997-08-19 Molecular Probes, Inc. Substituted unsymmetrical cyanine dyes with selected permeability
US5734058A (en) * 1995-11-09 1998-03-31 Biometric Imaging, Inc. Fluorescent DNA-Intercalating cyanine dyes including a positively charged benzothiazole substituent
JP2000508709A (ja) * 1996-04-19 2000-07-11 アマーシャム・ファルマシア・バイオテック・ユーケイ・リミテッド スクアラート染料類および蛍光配列決定法におけるそれらの使用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0034394A2 *

Also Published As

Publication number Publication date
WO2000034394A3 (fr) 2002-10-31
WO2000034394A2 (fr) 2000-06-15

Similar Documents

Publication Publication Date Title
DE69617531T2 (de) Fluoreszierende Markierungskomplexe mit grossem Stokes-Shift die durch Verbindung von Cyaninen und anderen resonanzenergieübertragungfähigen Fluorochromen zusammengestellt sind
EP1283855B1 (fr) Colorants marqueurs du domaine du proche infrarouge stables a base de polymethines de benzopyrylium
DE69731179T2 (de) Fluorierte xanthenderivate
DE60116510T2 (de) Cyaninfarbstoffe
DE60005787T2 (de) Wasserlösliche rhodaminfarbstoffe und ihre konjugate
DE69907185T2 (de) Verfahren und reaktiv für einen energietransfer-assay
EP1318177B1 (fr) Composé, en particulier colorant marqueur, à base de polyméthines
DE10080558B4 (de) Laser-kompatible NIR-Marker-Farbstoffe
DE69624623T2 (de) Versteifte Monomethin-Cyaninfarbstoffe
EP1320571B1 (fr) Fluorochromes a 3-spirocyanines et leur utilisation dans des essais biologiques
DE19937024A1 (de) Verwendung von Acylsulfonamido substituierten Polymethin-Farbstoffen als Fluoreszenz-Farbstoffe und/oder Marker
DE4137934A1 (de) Neue pentacyklische verbindungen und ihre verwendung als absorptions- oder fluoreszenzfarbstoffe
EP1535969B1 (fr) Nouveaux colorants polymethine à base de coumarine avec Stoke's-Shift réglable
EP1273584B1 (fr) Composés merocyanines basés sur 2- ou 4-chromenyliden et leur utilisation
EP2886542B1 (fr) Colorants de marqueur à base de benzoxazoles pour l'excitation UV et à ondes courtes avec grand décalage de Stokes
EP1325084A2 (fr) Colorants du type pyridine et quinoleine utilises comme marqueurs pour des biomolecules, des polymeres, des medicaments et des particules
EP1272566B1 (fr) Marqueur fluorescent
DE10025820C2 (de) Stabile NIR-Marker-Farbstoffe auf der Basis von Benzopyrylium-Polymethinen
DE19856152A1 (de) Pyridin- und Chinolinfarbstoffe als Marker für Biomoleküle, Polymere und Arzneistoffe
DE102018124199B4 (de) Neue Fluoreszenzfarbstoffe, deren Synthese und neue Analyseverfahren für die Glycan-Analytik
DE102012205807A1 (de) Cyanin-Farbstoffe
EP4127069A1 (fr) Fluorochromes à large déplacement de stokes à base de sels de benzopyrylium pontés
EP1314981A2 (fr) Fluorochromes à benzo[c,d]indole pour marquer des biomolécules et des particules de polymères
DE19815659A1 (de) Reaktive Quadratsäure- und Croconsäure-Farbstoffe als Marker für Biomoleküle und Arzneistoffe

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021218

AK Designated contracting states

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LEHMANN, FRANK

Inventor name: PROBST, MARIO

Inventor name: WOLFBEIS, OTTO, SAMUEL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060627